Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
申请人:Pfizer Inc.
公开号:US06262046B1
公开(公告)日:2001-07-17
Compounds of the formula (I):
where X1, A, Ar1, X and R are as defined in the specification, and pharmaceutically-acceptable salts thereof, are new, and are useful as tachykinin inhibitors which act at the NK1, NK2 and NK3 receptors or a combination of two or more thereof.
This invention discloses and claims an industrial method for the production of azetidine derivatives, such as, N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulphonamide.
[EN] METHOD AND INTERMEDIATES FOR THE PREPARATION OF DERIVATIVES OF N-(1-BENZHYDRYL-AZETIDIN-3-YL)-N-PHENYL-METHYLSULPHONAMIDE<br/>[FR] PROCEDE ET INTERMEDIAIRES DE PREPARATION DE DERIVES DE N-(1-BENZHYDRYL-AZETIDIN-3-YL)-N-PHENYL-METHYLSULFONAMIDE
申请人:AVENTIS PHARMA SA
公开号:WO2006040464A1
公开(公告)日:2006-04-20
Nouveau procédé de synthèse du N-1-[bis-(4-chlorophényl)méthyl]azétidin-3-yl}-N-(3,5-difluorophényl)-méthylsulfonamide.
[EN] METHOD FOR PREPARING AZETIDINE DERIVATIVES<br/>[FR] PROCEDE DE PREPARATION DE DERIVES D ' AZETIDINE
申请人:SANOFI AVENTIS
公开号:WO2009103883A1
公开(公告)日:2009-08-27
Nouveau procédé de synthèse de dérivés d'azétidines de type N-(1-benzhydryl-azetidin-3-yl)- N-phényl-méthylsulfonamide pour une production industrielle.